Skip to main content
Caplight Logo









Epana Bio

Epana Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.epana.bio/

Last Round

Seed

Mar 1, 2025

Total Funding Raised

$11M

Company Overview

Epana Bio is a biotechnology company that develops targeted therapies for autoimmune diseases using genomics and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryprecision medicineautoimmune diseaseT-cell engagersTCEbispecific antibodiesAI drug discoverygenomicstargeted cell depletionbiotech startupin silico drug discoverytherapeutic pipelineAI-driven biotechdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epana Bio Comparables

Compare Epana Bio with similar companies based on industry and business-model similarity.

Epana Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dren Bio
77%
UCB
76%
Cullinan Oncology
75%

Epana Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2025

Epana Bio Investors

Notable investors and investment history

Epana Bio investors
InvestorRounds
Refactor CapitalSeed
South Park CommonsSeed
Hawktail ManagementSeed
NomadsSeed
Breakout VenturesSeed
82VSSeed
DimensionSeed

Epana Bio Filings

Explore SEC and related filing metadata, where available.

Epana Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Epana Bio's valuation, stock price, and market status.

Is Epana Bio a public or private company?

Epana Bio is a private company.

What is the current stock price of Epana Bio?

Epana Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Epana Bio worth (valuation)?

Valuation information for Epana Bio is not publicly available.

Can I buy Epana Bio stock?

Epana Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Epana Bio's last funding round?

Epana Bio's most recent funding round was Seed on March 1, 2025.

Who are the main investors in Epana Bio?

Key investors in Epana Bio include South Park Commons, Breakout Ventures, 82VS, Dimension, KdT Ventures.

Will Epana Bio IPO soon?

No public IPO plans have been announced for Epana Bio.

How can I track Epana Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epana Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Year Founded2024
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?